Bellevue Group’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXNX
UOC
AAM
MF
Bellevue Group's AXNX Position: Q1 2024 in Review
Bellevue Group sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 1,833,165 shares — an estimated $114M sold.
Bellevue Group first reported a position in AXNX in Q1 2020 and held it in 16 quarters. The position peaked at $154M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.
- Bellevue Group reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Bellevue Group sold 1,833,165 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $114M.
- Bellevue Group first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
- Bellevue Group's Axonics, Inc. Common Stock position peaked at $154M in Q3 2022.
- 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.
Based on Bellevue Group's 13F filing for Q1 2024, filed 15 May 2024.